BBB disruption is increased in AD patients, which may be due to pathological changes and factors associated with AD, such as Aβ pathology, tau pathology, neuroinflammation, apolipoprotein E epsilon4 (ApoE ε4) allele, and advanced age. This evidence concerns the gene APOE and Alzheimer disease.